- Medical Physics
- Radiation Oncology
- Proton Therapy
- +۳ مورد دیگر
Sara Margareta Cecilia Pilskog serves as an Associate Professor in the Department of Physics and Technology at the University of Bergen, Norway, with dual affiliation at Haukeland University Hospital's Department of Cancer Treatment and Medical Physics. Her research bridges theoretical medical physics and clinical oncology applications, focusing on precision radiotherapy techniques and biological optimization. Her primary research interests center on proton therapy innovation, where she investigates biological optimization strategies using linear energy transfer (LET) and relative biological effectiveness (RBE) modeling. She develops adaptive radiotherapy frameworks to address inter-fractional motion in pelvic cancers, particularly prostate and rectal malignancies. Her work also pioneers neutron-based in-vivo range verification systems and statistical deformation models for dose accumulation. Current projects emphasize reducing treatment margins through anatomical robustness and optimizing biological dose distributions for organ sparing. Analysis of her 15 most recent publications reveals a dominant focus on improving proton therapy precision for pelvic cancers through biological modeling and motion management. Approximately 70% of her work addresses prostate cancer applications, with significant contributions to adaptive strategies for inter-fractional changes and biological optimization techniques. Her research consistently employs Monte Carlo simulations (particularly FLUKA) and clinical data analysis to translate theoretical models into clinically viable solutions. No scientific awards were documented in the provided materials. While specific advising details remain unreported, her collaborative patterns indicate active mentorship within the University of Bergen's medical physics research ecosystem. Her publications consistently involve junior co-authors from clinical physics teams at Haukeland University Hospital, suggesting hands-on supervision of technical staff and research fellows in radiotherapy innovation projects. Grant funding appears primarily channeled through institutional hospital-university partnerships focused on clinical translation of advanced radiotherapy techniques. Dr. Pilskog operates within the University of Bergen's medical physics research cluster that maintains close operational ties to Haukeland University Hospital's radiotherapy department. This integrated academic-clinical environment enables direct implementation of her research on adaptive proton therapy and biological optimization into clinical workflows, with particular emphasis on pelvic cancer treatment protocols. The team utilizes advanced Monte Carlo simulation platforms and clinical treatment planning systems to develop and validate next-generation radiotherapy approaches.





